Latest
industry research report on: Pulmonary Embolism Diagnostic Market :
Industry Size, Share, Research, Reviews, Analysis, Strategies,
Demand, Growth, Segmentation, Parameters, Forecasts
The report titled Pulmonary
Embolism Diagnostic
Market: Size, Trends & Forecasts (2017-2021), provides an
in-depth analysis of the developed region pulmonary embolism
diagnostic market by value, by volume (number of patients), by
segments, etc.
The report provides an analysis
of the developed regions such as Canada, Australia and Europe on the
basis of diagnostics penetration and the regions such as the US with
an addressable market opportunity for the diagnostics penetration.
The
report also assesses the key opportunities in the market and outlines
the factors that are and will be driving the growth of the industry.
Growth of the pulmonary embolism diagnostics market has also been
forecasted for the period 2017-2021, taking into consideration the
previous growth patterns, the growth drivers and the current and
future trends.
The
competition in the pulmonary embolism diagnostic market, especially
V/Q scan is dominated by one big player at global level, Cyclopharm
and at regional level, in the US, the competition is dominated by
Lantheus Holdings, Inc. (Xe-133).
Further,
key players of the global pulmonary thromboembolism diagnostic market
Cyclopharm, Philips, Siemens and Jubilant LifeSciences Limited are
also profiled with their financial information and respective
business strategies.
Country
Coverage
- Developed Regions (Canada, Europe, Australia and Parts of Asia)
- The US
Company
Coverage
- Cyclopharm
- Jubilant LifeSciences Limited
- Philips
- Siemens
Executive
Summary
Venous
Thromboembolism (VTE) is a type of blood clot that starts in the
vein. Most commonly VTE starts in the legs of the patient, however,
it could occur in any other part of the body also. There are two
types of VTE: Deep Vein Thromboembolism (DVT) and Pulmonary Embolism
(PE).
The
pulmonary embolism generally occurs due to DVTs or pelvic vein
thrombosis.
Pulmonary
embolism is a condition where the clot that is formed deep into the
veins of the patient legs (or in any other body part) breaks off and
travels through the bloodstream to the lungs. The clot has a tendency
to block a blood vessel in the lungs and hence damage them.
Pulmonary
embolism is not a disease rather it is a complication of underlying
VTE. There are several risk factors for pulmonary embolism such as
cancer, obesity, sedentary lifestyle, age factor, major surgery,
genetic blood clotting disorder or fracture of the hip or leg, etc.
The onset of pulmonary embolism is depicted by shortness of breath,
sudden chest pain and coughing blood. These symptoms are then
followed by other symptoms such as flank pain, wheezing, cardiac
murmur, etc.
There
are different types of tests done to detect pulmonary embolism,
however, Computed Tomography Pulmonary Angiogram (CTPA) is the gold
standard for detecting pulmonary embolism. Another alternative test
done to detect pulmonary embolism is Ventilation-Perfusion (V/Q)
Scanning.
Since
prevention is better than cure, a healthy lifestyle is most commonly
prescribed to prevent pulmonary embolism. However, pulmonary embolism
is managed majorly through intake of anticoagulants, thrombolytics,
vena cava filter and compression stockings.
The
global pulmonary embolism diagnostics market is anticipated to
increase at a significant CAGR during the years 2017-2021. The
pulmonary embolism diagnostic market is expected to increase due to
growth in number of cancer patients, aging population, increase in
per-capita healthcare expenditure, etc. Yet the market faces some
challenges such as, prohibition of Technegas (an agent of V/Q Scan)
in the US and introduction of Novel Oral anticoagulants.
About
us
MarketResearchReports.biz
is the most comprehensive collection of market research reports.
MarketResearchReports.Biz services are specially designed to save
time and money for our clients. We are a one stop solution for all
your research needs, our main offerings are syndicated research
reports, custom research, subscription access and consulting
services. We serve all sizes and types of companies spanning across
various industries.
Contact
Mr.
Nachiket
State
Tower
90
Sate Street, Suite 700
Albany,
NY 12207
Tel:
+1-518-621-2074
